BAMRASNARADURA INFECTIOUS DISEASES INSTITUTE
🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- -
- Established
- 1958-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
9
Active:0
Completed:6
Trial Phases
2 Phases
Phase 3:2
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Phase 3
2 (40.0%)Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure
Phase 4
Completed
- Conditions
- HIVAIDSLopinavirTreatment Failure
- Interventions
- Drug: optimized background regimens (OBRs)
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Target Recruit Count
- 63
- Registration Number
- NCT01189695
- Locations
- 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity
Completed
- Conditions
- Treatment Failure, HIV or AIDSCD4 Cell Counts
- Interventions
- Drug: Efavirenz-based regimens
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Target Recruit Count
- 559
- Registration Number
- NCT01044810
- Locations
- 🇹🇭
Bamrasnaradura Infectious Disease Institute, Nonthaburi, Thailand
Appropriate Timing of HAART in Co-infected HIV/TB Patients
Phase 4
Terminated
- Conditions
- TuberculosisHIV Infections
- Interventions
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2011-11-17
- Lead Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Target Recruit Count
- 156
- Registration Number
- NCT01014481
- Locations
- 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
Ritonavir-boosted Lopinavir Monotherapy
Phase 3
Completed
- Conditions
- HIV
- Interventions
- Drug: lopinavir/ritonavir soft gel capsule
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2011-11-11
- Lead Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01002898
- Locations
- 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
Durability of Nevirapine-Based Antiretroviral Regimen
Phase 4
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2008-07-08
- Lead Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Target Recruit Count
- 140
- Registration Number
- NCT00703898
- Locations
- 🇹🇭
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
- Prev
- 1
- 2
- Next
News
No news found